Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes
Recombinant DNA -- Experiments -- Quality control. : The planned release of live organisms modified by recombinant DNA techniques : points to consider in the preparation of proposals for genetic assessment by the Committee / Recombinant DNA Monitoring Committee
Recombinant DNA -- Law and legislation. : Monitoring recombinant DNA technology : a five year review / Department of Industry, Technology and Commerce, Recombinant DNA Monitoring Committee
Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected
Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers
Recombinant erythropoietin. : Erythropoietins and erythropoiesis : molecular, cellular, preclinical, and clinical biology / edited by G. Molineux, M.A. Foote, and S.G. Elliott
2006
1
Recombinant erythropoietin -- Therapeutic use : Recombinant human erythropoeitin (rhEPO) in clinical oncology : scientific and clinical aspects of anemia in cancer / Mohammad Resa Nowrousian (ed.)
2008
1
Recombinant Fusion Proteins -- See Also Immunotoxins
Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect